What is the pathophysiology of Diabetic Ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Diabetic ketoacidosis (DKA) is primarily caused by a reduction in the net effective action of circulating insulin coupled with a concomitant elevation of counterregulatory hormones, leading to increased hepatic and renal glucose production and impaired glucose utilization in peripheral tissues, resulting in hyperglycemia, ketonemia, and metabolic acidosis. The pathophysiology of DKA involves a complex interplay of hormonal alterations, including a decrease in insulin levels and an increase in counterregulatory hormones such as glucagon, catecholamines, cortisol, and growth hormone 1. This leads to:

  • Increased hepatic and renal glucose production
  • Impaired glucose utilization in peripheral tissues
  • Hyperglycemia and changes in osmolality of the extracellular space
  • Release of free fatty acids into the circulation from adipose tissue (lipolysis)
  • Unrestrained hepatic fatty acid oxidation to ketone bodies (-hydroxybutyrate [-OHB] and acetoacetate), resulting in ketonemia and metabolic acidosis 1. The combination of insulin deficiency and increased counterregulatory hormones in DKA also leads to glycosuria, causing osmotic diuresis, with loss of water, sodium, potassium, and other electrolytes 1. Key factors contributing to the development of DKA include:
  • Inadequate insulin levels
  • Increased counterregulatory hormones
  • Hyperglycemia
  • Ketonemia
  • Metabolic acidosis
  • Electrolyte imbalances
  • Dehydration.

From the Research

Pathophysiology of Diabetic Ketoacidosis (DKA)

The pathophysiology of DKA is attributed to a combination of two hormonal abnormalities: a relative insulin insufficiency and stress hormone excess (glucagon, catecholamines, cortisol, and growth hormone) 2. This leads to impaired carbohydrate utilization and ketonaemia, resulting in metabolic acidosis 3, 2. The reduction in effective insulin action combined with increased counterregulatory hormones is a basic common pathophysiological mechanism in DKA 4.

Key Factors Contributing to DKA

  • Insulin deficiency, which can be due to withdrawal of exogenous insulin, pancreatic beta-cell failure, or insulin resistance 2
  • Stress hormone excess, which can be caused by factors such as fasting, stress, and dehydration 2
  • Increased lipolysis and production of excess fatty acids, leading to beta-oxidation and ketogenesis 4
  • Impaired glucose utilization, resulting in hyperglycemia and metabolic acidosis 3, 2

Consequences of DKA

  • Metabolic acidosis with loss of water through acidotic breaths 2
  • Rise in plasma lipids, hyperglycemia, and glycosuria, leading to osmotic diuresis and further loss of water 2
  • Excretion of partly neutralised ketoacids via the kidney, with loss of cations (Na+ and K+) 2
  • Net increase in protein catabolism, leading to an increased amino acid flux from muscle and an enhanced load of gluconeogenic precursor to the liver 2

Special Considerations

  • Euglycemic DKA, where patients present with normal blood glucose levels, can pose a challenge to diagnosis and management 5
  • The use of sodium glucose cotransporter 2 (SGLT2) inhibitors has been associated with an increased risk of euglycemic DKA 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Current concepts of the pathogenesis and management of diabetic ketoacidosis (DKA).

Annals of the Academy of Medicine, Singapore, 1983

Research

Ketoacidosis.

Southern medical journal, 1976

Research

Diabetic ketoacidosis and hyperosmolar hyperglycemic state.

Medizinische Klinik (Munich, Germany : 1983), 2006

Research

Euglycemic Diabetic Ketoacidosis: A Review.

Current diabetes reviews, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.